1Heinemann L, Fleming GA, Petrie JR, et al. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, ad- verse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [ J ]. Di- abetes Care, 2015, 38(4) : 716 -722.
2Gabriel J. Subcutaneous infusion in palliative care: a focus on the neria soft 90 infusion set[J]. Int J Palliat Nurs, 2014, 20( 11 ) : 538 - 541.
3Jolles S, Orange JS, Gardulf A, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease [ J ]. Clin Exp Immunol, 2015, 179(2) : 146 -160.
4Malin SK, Kashyap SR, Hammel J, et al. Adjusting glucose - stimulated insulin secretion for adipose insulin resistance: an index of 13 -cell function in obese adults[ J]. Diabetes Care, 2014, 37 ( 11 ) : 2940 - 2946.
5Traore AN, Chan AK, Webert KE, et al. First analysis of 10 - year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System[ J ]. Haemophilia, 2014, 20 (4) : 251 - 259.
